Get the Stockscreener App
74.15
0.15%
-0.11
After Hours:
74.16
0.010
+0.01%
Hologic Inc stock is traded at $74.15, with a volume of 5.29M.
It is down -0.15% in the last 24 hours and up +12.48% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$74.26
Open:
$74.26
24h Volume:
5.29M
Relative Volume:
1.82
Market Cap:
$16.49B
Revenue:
$4.04B
Net Income/Loss:
$557.10M
P/E Ratio:
30.77
EPS:
2.4102
Net Cash Flow:
$916.70M
1W Performance:
+0.07%
1M Performance:
+12.48%
6M Performance:
+33.94%
1Y Performance:
-4.37%
1-Day Range:
$74.09
$74.36
1-Week Range:
$74.08
$74.66
52-Week Range:
$51.90
$80.31
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.15 | 16.53B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Will Hologic Inc. (HO1) stock beat Nasdaq index returns2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
Can Hologic Inc. (HO1) stock attract ESG investmentsLong Setup & Fast Momentum Entry Tips - newser.com
How Hologic Inc. (HO1) stock compares with market leadersDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
Is Hologic Inc. (HO1) stock among top earnings playsJuly 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Best data tools to analyze Hologic Inc. stockQuarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com
How Hologic Inc. (HO1) stock responds to bond marketWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Is a relief rally coming for Hologic Inc. holdersWeekly Trade Report & Long-Term Growth Stock Strategies - newser.com
Using Ichimoku Cloud for Hologic Inc. technicalsPortfolio Update Report & Growth Oriented Trade Recommendations - newser.com
Statistical indicators supporting Hologic Inc.’s strengthTrade Entry Report & Free Verified High Yield Trade Plans - newser.com
Why retail investors pile into Hologic Inc. stockPortfolio Performance Report & Technical Confirmation Trade Alerts - newser.com
Blackstone, TPG said to be nearing over $17B deal for Hologic - MSN
Does Hologic Inc. stock trade at a discount to peersMarket Risk Analysis & Growth Focused Entry Reports - newser.com
How high can Hologic Inc. stock go2025 Market Overview & Risk Managed Trade Strategies - newser.com
How to recover losses in Hologic Inc. stock2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Precision Trading with Hologic Inc. (HOLX) Risk Zones - news.stocktradersdaily.com
P/E Ratio Insights for Hologic - Benzinga
Will Hologic Inc. stock attract ESG investorsMarket Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Hologic (HOLX): Exploring Current Valuation After Recent Share Price Momentum - Yahoo Finance
Hologic’s Genius™ Digital Diagnostics System Receives Expanded CE Marking for Cell and Tissue Imaging - Voice Of HealthCare
Hologic’s Digital Pathology System Wins EU Nod for Whole Slide Imaging - Medical Product Outsourcing
How Hologic Inc. stock benefits from tech adoptionTrade Risk Summary & Technical Pattern Based Signals - newser.com
Hologic Expands European Reach of Genius Digital Diagnostics System - Yahoo Finance
Is Hologic Inc a good long term investmentDebt-to-Equity Ratio Analysis & Small Entry Investment Ideas - earlytimes.in
Here's Why Hologic (HOLX) is a Strong Momentum Stock - sharewise.com
What margin trends mean for Hologic Inc. stockPortfolio Profit Report & Weekly Stock Performance Updates - newser.com
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
1.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):